BRCA1 and cancer: This highlighted the need to ensure ongoing support in making decisions around risk management.There are currently no set models of care for hospitals in Ireland on the provision of preventative and screening care for the BRCA1/2 alteration population – the uncertainty of being unaffected by cancer, while attending symptomatic oncology services was felt throughout the BRCA1/2 alteration population: “You’re sort of going in as a blooming healthy person into a cancer clinic and you’re sort of going, lads, you know, you should just sort this out?”.